Clinical Trial Update: Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of XC8 40 mg film-coated tablets for dry non-productive cough associated with acute respiratory viral infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold
• Influenza Human
• Respiratory Infection

Drugs mentioned

• XC8

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Common Cold, Acute Respiratory Infection | Phase 3 | Status: COMPLETED